Patents by Inventor Gordon Wayne Dyer

Gordon Wayne Dyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11678652
    Abstract: The present invention is about turning the gaseous envelope that encoats, protects certain arthropods from their external environment against them. It teaches to apply radiation to the arthropods body in order to dysfunction the exacting geometry needed to maintain this protective envelope. This absorbed radiation thus makes the arthropod vulnerable to pesticides and other chemical agents. It also interferes with the arthropods ability to adequately breathe through their plastron covering by forcing it to increase its rate of metabolism via this absorbed radiation.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: June 20, 2023
    Inventor: Gordon Wayne Dyer
  • Patent number: 11457626
    Abstract: The present invention about using chemicals to interfere with the ability of certain arthropods to shield themselves from their external environment. It teaches to apply chemicals to a specialized portions of the arthropod's body that maintain a gaseous envelope that encoats, protects and extends from the arthropod's skin and, if present, breathing hole. This chemical application causes a failure of this protective envelope, making the arthropod vulnerable its external environment such as to pesticides and can also lead to problems with its ability to breathe.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: October 4, 2022
    Inventor: Gordon Wayne Dyer
  • Publication number: 20140121645
    Abstract: The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (CVCS) via a Valsalva maneuver. Because the CVCS is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply. Instead, because in its closed-system blood can flow in any direction, the blood of the CVCS and any medicaments that it contains will be drawn to any portion of it where there is increased outflow, such as the copious venousderived sinus fluid drainage present during nasal allergy or nasal infection. Thus, the very nasal congestion that impedes the effectiveness of direct medicament application, such as seen with nasal inhalers or systemic antibiotics, aids in applying the medicament indirectly to the nasal sinuses via the CVCS.
    Type: Application
    Filed: July 16, 2012
    Publication date: May 1, 2014
    Inventor: Gordon Wayne Dyer
  • Publication number: 20110301569
    Abstract: The present invention provides an indirect method and accompanying apparatus for supplying a high concentration of medicaments, particularly antibiotics, to the nasal sinuses by first loading the medicament into the cerebrospinal venous system (CVCS) via a Valsalva manuever. Because the CVCS is a valveless, three-dimensional closed system, traditional physiological dogma such as veins always draining tissues does not always apply. Instead, because in its closed-system blood can flow in any direction, the blood of the CVCS and any medicaments that it contains will be drawn to any portion of it where there is increased outflow, such as the copious venous-derived sinus fluid drainage present during nasal allergy or nasal infection. Thus, the very nasal congestion that impedes the effectiveness of direct medicament application, such as seen with nasal inhalers or systemic antibiotics, aids in applying the medicament indirectly to the nasal sinuses via the CVCS.
    Type: Application
    Filed: August 16, 2011
    Publication date: December 8, 2011
    Inventor: Gordon Wayne Dyer
  • Publication number: 20040248982
    Abstract: The invention treats proteinase-related disorders by interfering with the binding of the metal needed by matrix metalloproteinases, such as PLA-2. The compounds used are known microbial-based chelators of known high solubility. For example, dipicolinic acid has a high affinity to calcium and is soluble in both water and glycerin, as might be expected due to its role in the formation of bacterial endospores. Thus, unlike most chelation agents, the compounds are intended to be permeable enough to cross a vertebrate's cell membrane, a prerequisite for meaningful inhibition of protein-regulated cellular functions such as the inflammatory cascade and accompanying formation of free fatty acids.
    Type: Application
    Filed: June 9, 2003
    Publication date: December 9, 2004
    Inventor: Gordon Wayne Dyer
  • Patent number: 6797104
    Abstract: A method for making an optical composite composed of glass and plastic is disclosed. The method can be used to create a photochromic lens of high optical and refractive quality that is both scratch resistant and of high impact resistance. The method can also be used to create a strong sheath and/or cladding for an optic fiber. The method can also be used to create a scratch resistant coating for polycarbonate material, such as bulletproof glass. Vacuum pressure and optical contacting are used to hold the glass and plastic portions together. A flexible, peripheral seal, whose kinetic reaction strength has been enhanced with microwave radiation, is used maintain the vacuum adhesion of the glass and the plastic. This structural seal is located in a peripheral, non-optical portion of the optical composite to minimize any interference the seal may have with the optical function of the composite.
    Type: Grant
    Filed: September 26, 2000
    Date of Patent: September 28, 2004
    Inventor: Gordon Wayne Dyer
  • Publication number: 20020098154
    Abstract: The present invention provides a method and accompanying apparatus for supplying medications, particularly antibiotics, to the deeper parts areas of the sinuses. The pressure of application from use of the Valsalva maneuver and the use of medications that are both water and fat-soluble aids the medications in penetrating deep into the sinuses. When the medication is an antibiotic, this has the benefit of delivering a high level of antibiosis using a line of antibiotics that the likely bacteria will not be as resistant to because they have not had as much prior exposure to this antibiotic. The lighter-than-air propellant aids in delivering the medication to those sinus areas superior to the nose. If the infection extends to the eardrums, making the Valsalva maneuver painful, or if the patient is simply unusually sensitive, then earplugs to reduce the stress on the eardrums may be worn while the patient performs the Valsalva maneuver.
    Type: Application
    Filed: January 20, 2001
    Publication date: July 25, 2002
    Inventor: Gordon Wayne Dyer